Welcome to eNeura.com

Please choose your country and click Go

GO

The Cost of Migraine

What does your migraine cost you today?

Are you losing income or vacation time because of taking sick days?

Do you find that you have trouble focusing at work?

Does migraine make you miss out on time with family and friends?

Do the symptoms of migraine—or the side effects of migraine medications—hold you back from being your best self?

The lost work time and diminished quality of life—caused by migraine pain and medication side effects—lead to an enormous cost, both financially and emotionally.

Migraine has a devastating financial impact of nearly £3.42 billion on the UK economy every year,8 and its impact on patients at a personal level is immeasurable.

The value of a clinically proven, non-drug treatment option cannot be underestimated. Scientists and doctors have been seeking such a treatment for years.

Now, headache specialists and patients recognise that the sTMS mini by eNeura can make an invaluable, life-changing difference for people with migraine.

Making sTMS treatment accessible

eNeura is committed to helping migraine patients have access to the relief they need, when they need it.

Before eNeura developed the sTMS mini, patients could only be treated in a specialist’s office with the help of trained technicians. Now, the sTMS mini allows sTMS treatment to be self-administered with a portable, simple-to-use device.

As any migraine patient knows, once headache pain strikes, making a specialist appointment—and getting to the doctor’s office—can be impossible. The portability of the sTMS mini is a major advance in migraine treatment.

In addition to designing the sTMS mini so it’s small enough to use at home and carry with you on the go, eNeura makes it easy to get treatment started: Our Customer Care representatives will coordinate your prescription with your doctor and arrange home delivery at your convenience.

Like any medical treatment, migraine treatment with the sTMS mini is not equally effective for every patient. For patients who respond well, this treatment can be life-changing.

My gain

For the first time in years, I have headache-free days.
— 48-year-old female
Indication: The sTMS mini™ by eNeura® is indicated for the prevention and acute treatment of migraine.
References

  1. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754-762.
  2. Lipton RB, Bigal ME, Diamond M. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-349.
  3. Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache. 1999;39(suppl 2):S20-S26.
  4. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005;118(suppl 1):3S-10S.
  5. Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N Eng J Med. 2002;346(4):257-270.
  6. Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. 2012;15(suppl 1):15S-22S.
  7. Hazard E, Munakata J, Bigal ME, Rupnow MF, Lipton RB. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. Value Health. 2009;12(1):55-64.
  8. All-Party Parliamentary Group on Primary Headache Disorders. Headache Disorders – not respected, not resourced. London, UK: House of Commons; 2010.